Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.4K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

440
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
440
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

511
The pathophysiology of pneumonia involves the following steps:
511
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

425
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
425
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.8K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

325
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
325

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections.

The Pediatric infectious disease journal·2026
Same author

Correlation Between Renal Biomarkers, Glomerular Filtration Rate, and Meropenem Clearance in Pediatric Septic Shock.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026
Same author

Sex-specific trends in incident stroke: The Framingham Heart Study.

medRxiv : the preprint server for health sciences·2026
Same author

Pneumococcal Pneumonia in Hospitalized Children: 2017-2023.

Pediatrics·2026
Same author

Lifelong trajectories of modifiable vascular risk factors and relation to cerebral small vessel disease in the Framingham Heart Study.

medRxiv : the preprint server for health sciences·2026
Same author

Successful Bacteriophage Treatment of a Recalcitrant Intra-Abdominal Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa in a 2-Year-Old Child.

The Journal of pediatrics·2026
Same journal

A systematic review of the use of antiretroviral drugs to prevent HIV in neonates and infants.

Journal of the Pediatric Infectious Diseases Society·2026
Same journal

Pediatric inpatient influenza vaccination before, during and after the COVID-19 pandemic.

Journal of the Pediatric Infectious Diseases Society·2026
Same journal

Respiratory bacterial epidemiology at three primary ciliary dyskinesia clinical centers.

Journal of the Pediatric Infectious Diseases Society·2026
Same journal

Epidemiology and Outcomes of Mycobacterium abscessus Infections in immunocompetent children in Singapore.

Journal of the Pediatric Infectious Diseases Society·2026
Same journal

Trimethoprim-Sulfamethoxazole Treatment for Severe Pertussis in Infants Younger Than 2 months During a Macrolide-Resistant Bordetella pertussis Outbreak: A Case Series.

Journal of the Pediatric Infectious Diseases Society·2026
Same journal

Disinvestment in Global Health Threatens Global Security and Children's Health Everywhere.

Journal of the Pediatric Infectious Diseases Society·2026
See all related articles

Related Experiment Video

Updated: Sep 7, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K

Decrease in Pediatric Invasive Pneumococcal Disease During the COVID-19 Pandemic.

Adriana Sarmiento Clemente1, Sheldon L Kaplan1, William J Barson2

  • 1Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Journal of the Pediatric Infectious Diseases Society
|June 22, 2022
PubMed
Summary
This summary is machine-generated.

Public health measures against SARS-CoV-2 in 2020 lowered other viral infections. Invasive pneumococcal disease incidence in children dropped by 46%, likely due to reduced droplet and viral pathogen transmission.

Keywords:
childreninvasive pneumococcal diseasepandemic

More Related Videos

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

17.0K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.6K

Related Experiment Videos

Last Updated: Sep 7, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K
Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

17.0K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.6K

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Non-pharmaceutical interventions (NPIs) were implemented globally in 2020 to curb severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission.
  • These measures, including masking, social distancing, and enhanced hygiene, significantly altered respiratory virus circulation patterns.
  • The impact of these NPIs on other bacterial and viral infections, particularly in pediatric populations, remains an area of active investigation.

Purpose of the Study:

  • To investigate the effect of SARS-CoV-2 containment measures on the incidence of invasive pneumococcal disease (IPD) in children.
  • To determine if the reduction in other viral infections influenced IPD rates.
  • To explore potential mechanisms linking reduced viral transmission to changes in IPD incidence.

Main Methods:

  • Retrospective analysis of IPD case data from 7 children's hospitals in the United States.
  • Comparison of cumulative incidence of IPD in 2020 with a baseline period of 2017-2019.
  • Statistical analysis to assess the significance of observed changes in incidence.

Main Results:

  • A 46% decrease in the cumulative incidence of invasive pneumococcal disease was observed in 2020 compared to the 2017-2019 average.
  • The reduction in IPD occurred concurrently with widespread implementation of measures to limit SARS-CoV-2 transmission.
  • This finding suggests a potential link between reduced transmission of respiratory viruses and decreased rates of IPD.

Conclusions:

  • Non-pharmaceutical interventions aimed at controlling SARS-CoV-2 transmission were associated with a significant reduction in invasive pneumococcal disease incidence among children.
  • Limited droplet transmission of Streptococcus pneumoniae and the decreased circulation of preceding viral pathogens are plausible explanations for the observed decline in IPD.
  • Further research is warranted to elucidate the complex interplay between viral and bacterial respiratory pathogen dynamics under varying public health intervention scenarios.